Novo Nordisk A/S (NVO) Analyst Forecast

$58.86

$0.58 (-0.97%)
Last update: 03:15 PM EST
Day's range
$57.79
Day's range
$59.39

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
01/26/2026 BMO Capital Evan Seigerman $57.00 $63.80   -10.66%
12/03/2025 Morgan Stanley Thibault Boutherin $42.00 $47.43   -11.45%
11/25/2025 BMO Capital Evan Seigerman $46.00 $44.97   2.29%
10/14/2025 BMO Capital Evan Seigerman $55.00 $57.50   -4.35%
07/23/2025 Truist Financial Jailendra Singh $48.00 $70.03   -31.46%
10/17/2024 BMO Capital Evan Seigerman $156.00 $118.58   31.56%
09/11/2024 Cantor Fitzgerald Louise Chen $160.00 $135.23   18.32%
08/08/2024 BMO Capital Evan David Seigerman $160.00 $126.17   26.81%
06/10/2024 Argus Research Jasper Hellweg $160.00 $142.88   11.98%
05/30/2024 Goldman Sachs James Quigley $156.00 $132.68   17.58%
04/12/2024 BMO Capital Evan David Seigerman $163.00 $125.40   29.98%

Novo Nordisk A/S FAQ's

Novo Nordisk A/S has been rated by research analysts at BMO Capital, HSBC, Morgan Stanley, Truist Financial, Cantor Fitzgerald, Argus Research in the past 90 days.